How is the Neurocrine Biosciences, Inc. today?

The Neurocrine Biosciences, Inc. today is trading in the green, up by 0.18% at 95.06.

Neurocrine Biosciences, Inc. XNAS: NBIX

Neurocrine Biosciences, Inc. Live Share Price Today, Share Analysis and Chart

Name: Neurocrine Biosciences, Inc.: Is Infosys Ltd. worth buying?
Item: Neurocrine Biosciences, Inc.
Rating: 2.32015275
Author: Trendlyne DVM scores

Falling Comet

Download real time

95.06 0.17 (0.18%)

New 52W Low in past week

853.1K XNAS Volume

XNAS 15 Apr, 2025 2:23 PM (EDT)

Analyst Upgrade

Needham upgrades Neurocrine Bio to 'Buy'; cites positive physician survey of its drug, 'Crenessity' See details

High Financial Strength

61.1 / 100

Mid Valuation

32.5 / 100

Technically Bearish

30.9 / 100

Falling Comet These stocks are the ones with good quality and mid-range financial aspects. However, their weak technical aspect reduces the investor's interest. View Similar Embed DVM

161

1Yr Price target upside is 70%

24 analysts

Neurocrine Biosciences, Inc. Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Neurocrine Biosciences, Inc. FAQ

How is Neurocrine Biosciences, Inc. today?

Neurocrine Biosciences, Inc. today is trading in the green, and is up by 0.18% at 95.06.

How has Neurocrine Biosciences, Inc. performed historically?

Neurocrine Biosciences, Inc. is currently trading up 0.18% on an intraday basis. In the past week the stock rose 1.94%. stock has been down -31.86% in the past quarter and fell -29.41% in the past year. You can view this in the overview section.